BHR

Braemar is a small luxury-hotel REIT (13 properties, 3,028 rooms) with structurally poor economics for a common holder. FY2025 revenue fell 3.3% to $704M, operating income dropped 43.8% to $72.4M, and the company swung to a -$22.3M net loss (-$1.07 diluted EPS, ROE -16.1%). Its history is a string of losses (net income negative in four of the last five years), so 2025 is not an aberration. The balance sheet is stretched: $1.10B long-term debt against just $139M of equity (down 42.4% YoY) yields 9.64x liabilities/equity, retained earnings sit at -$569M, and operating cash flow of $40.8M (down 39%) barely exceeds the $47.3M of dividends being paid — the payout is not covered by cash generation.

The filing dominates the picture. Braemar is externally advised by Ashford LLC (Ashford Inc.), has no employees, and pays for a web of related-party services — a textbook conflicted external-management structure. On Aug 26, 2025 the board agreed to explore a sale, but the advisory termination fee is $574.8M, discounted to $480.0M plus accrued fees. That fee is roughly 3x the entire $157M market cap and exceeds total book equity — meaning any sale transaction first funnels a massive value transfer to the advisor before common shareholders see proceeds. Ashford already collected a $17.0M non-refundable payment on signing. This caps the upside from the very catalyst (a sale) that bulls would point to.